MIA
LLY icon

MeadowBrook Investment Advisors’s Eli Lilly LLY Stock Holding History

MeadowBrook Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$558K Buy
607
+28
+5% +$28.4K 0.49% 52
2025
Q4 		$622K Sell
579
-60
-9% -$57.4K 0.53% 48
2025
Q3 		$488K Buy
639
+39
+7% +$29K 0.42% 56
2025
Q2 		$468K Buy
600
+289
+93% +$225K 0.42% 58
2025
Q1 		$257K Buy
311
+285
+1,096% +$237K 0.24% 95
2024
Q4 		$20.1K Hold
26
– – 0.02% 225
2024
Q3 		$23K Buy
26
+11
+73% +$9.89K 0.02% 212
2024
Q2 		$13.6K Hold
15
– – 0.01% 225
2024
Q1 		$11.7K Buy
15
+7
+88% +$4.98K 0.01% 235
2023
Q4 		$4.66K Buy
+8
New +$4.67K ﹤0.01% 282

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MeadowBrook Investment Advisors's LLY Position: Q1 2026 in Review

MeadowBrook Investment Advisors increased its Eli Lilly (LLY) stake by 4.8% in Q1 2026, buying an estimated $28.4K and bringing the position to 607 shares worth $558K. The position accounts for 0.49% of the portfolio, ranked #52.

MeadowBrook Investment Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $622K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • MeadowBrook Investment Advisors held 607 shares of Eli Lilly worth $558K as of Q1 2026.
  • MeadowBrook Investment Advisors bought 28 Eli Lilly shares in Q1 2026, an estimated $28.4K.
  • Eli Lilly made up 0.49% of MeadowBrook Investment Advisors's portfolio in Q1 2026, its #52 holding.
  • MeadowBrook Investment Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • MeadowBrook Investment Advisors's Eli Lilly position peaked at $622K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on MeadowBrook Investment Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.